Donate
Home > Resources > Towards Preclinical Validation of Arbaclofen (R-baclofen) Treatment for 16p11.2 Deletion Syndrome.
Back to Resources

Towards Preclinical Validation of Arbaclofen (R-baclofen) Treatment for 16p11.2 Deletion Syndrome.

Distal Deletion, Proximal Deletion,

All,

This study found that arbaclofen helped improve learning and everyday-type behaviors in mouse models of 16p11.2 deletion without causing sedation, supporting careful clinical trials to see if it could one day help people with this genetic syndrome.

Learn More

Behavior, Brain, Cognitive Impact, Education, Treatment,

Back to Resources